Advanced ureteral carcinoma with supraclavicular mass: LONG-term survival after multimodality treatment a case report

Tadashi Oeda, Kunihiro Nozaki, Seiji Kai, Norihiro Kusumi, Atsushi Takamoto, Daisuke Manabe

Research output: Contribution to journalArticle

Abstract

A 55-year-old woman visited our institution because of a left supraclavicular mass noted two months earlier. Biopsy of the supraclavicular lymph nodes revealed metastasis of urothelial carcinoma CT scan showed marked left hydronephrosis, left ureteral tumor and multiple paraaortic lymph node swelling. With a diagnosis of left ureteral cancer with paraaortic lymph node and left supraclavicular lymph node metastases, radical surgery (left nephroureterectomy + pelvic and paraaortic lymph node dissection + left cervical lymph node dissection) was performed following three courses of combination chemotherapy (MEC ; Methotrexate 30 mg/m2, Epirubicin 50 mg/m 2, Cisplatin 100 mg/m2). Histopathologically, cancer cells were still present within the ureteral tumor, but no viable cells were observed in any of the lymph nodes. Three months postoperatively, left cervical lymph node swelling was found. This was resected and histopathologically confirmed as recurrence. Adjuvant chemotherapy was administered (MEC), but this was stopped because of grade 4 thrombocytopenia Five months later, another cervical lymph node recurrence was resected, followed by 50 Gy of external beam irradiation to the left cervical area Following irradiation, no evidence of recurrence has been found during a period of 8 years.

Original languageEnglish
Pages (from-to)329-334
Number of pages6
JournalNishinihon Journal of Urology
Volume72
Issue number6
Publication statusPublished - Jun 2010
Externally publishedYes

Fingerprint

Lymph Nodes
Carcinoma
Survival
Lymph Node Excision
Recurrence
Therapeutics
Ureteral Neoplasms
Neoplasm Metastasis
Neoplasms
Epirubicin
Hydronephrosis
Adjuvant Chemotherapy
Combination Drug Therapy
Methotrexate
Cisplatin
Biopsy

Keywords

  • Multimodality treatment long-term survival
  • Supraclavicular lymph node metastasis
  • Ureteral cancer

ASJC Scopus subject areas

  • Urology

Cite this

Advanced ureteral carcinoma with supraclavicular mass : LONG-term survival after multimodality treatment a case report. / Oeda, Tadashi; Nozaki, Kunihiro; Kai, Seiji; Kusumi, Norihiro; Takamoto, Atsushi; Manabe, Daisuke.

In: Nishinihon Journal of Urology, Vol. 72, No. 6, 06.2010, p. 329-334.

Research output: Contribution to journalArticle

Oeda, Tadashi ; Nozaki, Kunihiro ; Kai, Seiji ; Kusumi, Norihiro ; Takamoto, Atsushi ; Manabe, Daisuke. / Advanced ureteral carcinoma with supraclavicular mass : LONG-term survival after multimodality treatment a case report. In: Nishinihon Journal of Urology. 2010 ; Vol. 72, No. 6. pp. 329-334.
@article{728a4f4b4ac4455aa02adb9228e0e96b,
title = "Advanced ureteral carcinoma with supraclavicular mass: LONG-term survival after multimodality treatment a case report",
abstract = "A 55-year-old woman visited our institution because of a left supraclavicular mass noted two months earlier. Biopsy of the supraclavicular lymph nodes revealed metastasis of urothelial carcinoma CT scan showed marked left hydronephrosis, left ureteral tumor and multiple paraaortic lymph node swelling. With a diagnosis of left ureteral cancer with paraaortic lymph node and left supraclavicular lymph node metastases, radical surgery (left nephroureterectomy + pelvic and paraaortic lymph node dissection + left cervical lymph node dissection) was performed following three courses of combination chemotherapy (MEC ; Methotrexate 30 mg/m2, Epirubicin 50 mg/m 2, Cisplatin 100 mg/m2). Histopathologically, cancer cells were still present within the ureteral tumor, but no viable cells were observed in any of the lymph nodes. Three months postoperatively, left cervical lymph node swelling was found. This was resected and histopathologically confirmed as recurrence. Adjuvant chemotherapy was administered (MEC), but this was stopped because of grade 4 thrombocytopenia Five months later, another cervical lymph node recurrence was resected, followed by 50 Gy of external beam irradiation to the left cervical area Following irradiation, no evidence of recurrence has been found during a period of 8 years.",
keywords = "Multimodality treatment long-term survival, Supraclavicular lymph node metastasis, Ureteral cancer",
author = "Tadashi Oeda and Kunihiro Nozaki and Seiji Kai and Norihiro Kusumi and Atsushi Takamoto and Daisuke Manabe",
year = "2010",
month = "6",
language = "English",
volume = "72",
pages = "329--334",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "6",

}

TY - JOUR

T1 - Advanced ureteral carcinoma with supraclavicular mass

T2 - LONG-term survival after multimodality treatment a case report

AU - Oeda, Tadashi

AU - Nozaki, Kunihiro

AU - Kai, Seiji

AU - Kusumi, Norihiro

AU - Takamoto, Atsushi

AU - Manabe, Daisuke

PY - 2010/6

Y1 - 2010/6

N2 - A 55-year-old woman visited our institution because of a left supraclavicular mass noted two months earlier. Biopsy of the supraclavicular lymph nodes revealed metastasis of urothelial carcinoma CT scan showed marked left hydronephrosis, left ureteral tumor and multiple paraaortic lymph node swelling. With a diagnosis of left ureteral cancer with paraaortic lymph node and left supraclavicular lymph node metastases, radical surgery (left nephroureterectomy + pelvic and paraaortic lymph node dissection + left cervical lymph node dissection) was performed following three courses of combination chemotherapy (MEC ; Methotrexate 30 mg/m2, Epirubicin 50 mg/m 2, Cisplatin 100 mg/m2). Histopathologically, cancer cells were still present within the ureteral tumor, but no viable cells were observed in any of the lymph nodes. Three months postoperatively, left cervical lymph node swelling was found. This was resected and histopathologically confirmed as recurrence. Adjuvant chemotherapy was administered (MEC), but this was stopped because of grade 4 thrombocytopenia Five months later, another cervical lymph node recurrence was resected, followed by 50 Gy of external beam irradiation to the left cervical area Following irradiation, no evidence of recurrence has been found during a period of 8 years.

AB - A 55-year-old woman visited our institution because of a left supraclavicular mass noted two months earlier. Biopsy of the supraclavicular lymph nodes revealed metastasis of urothelial carcinoma CT scan showed marked left hydronephrosis, left ureteral tumor and multiple paraaortic lymph node swelling. With a diagnosis of left ureteral cancer with paraaortic lymph node and left supraclavicular lymph node metastases, radical surgery (left nephroureterectomy + pelvic and paraaortic lymph node dissection + left cervical lymph node dissection) was performed following three courses of combination chemotherapy (MEC ; Methotrexate 30 mg/m2, Epirubicin 50 mg/m 2, Cisplatin 100 mg/m2). Histopathologically, cancer cells were still present within the ureteral tumor, but no viable cells were observed in any of the lymph nodes. Three months postoperatively, left cervical lymph node swelling was found. This was resected and histopathologically confirmed as recurrence. Adjuvant chemotherapy was administered (MEC), but this was stopped because of grade 4 thrombocytopenia Five months later, another cervical lymph node recurrence was resected, followed by 50 Gy of external beam irradiation to the left cervical area Following irradiation, no evidence of recurrence has been found during a period of 8 years.

KW - Multimodality treatment long-term survival

KW - Supraclavicular lymph node metastasis

KW - Ureteral cancer

UR - http://www.scopus.com/inward/record.url?scp=77954329193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954329193&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77954329193

VL - 72

SP - 329

EP - 334

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 6

ER -